Alerts will be sent to your verified email
Verify Email
OXYGENTAPH
|
Oxygenta Pharma
|
Gennex Lab
|
Sat Kartar Shopping
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.1 % | 7.82 % | 85.71 % |
|
5yr Avg Net Profit Margin
|
-16.74 % | 7.88 % | 4.16 % |
|
Price to Book
|
0.0 | 1.53 | 5.15 |
|
P/E
|
0.0 | 16.97 | 26.95 |
|
5yr Avg Cash Conversion Cycle
|
-56.32 Days | 43.23 Days | -188.77 Days |
|
5yr Average Interest Coverage Ratio
|
-3.11 | 6.21 | 13.86 |
|
5yr Avg ROCE
|
-80.86 % | 11.17 % | 56.52 % |
|
5yr Avg Operating Profit Margin
|
-18.99 % | 10.47 % | 6.86 % |
|
5 yr average Debt to Equity
|
-1.55 | 0.18 | 3.01 |
|
5yr CAGR Net Profit
|
-9.68 % | 43.63 % | 47.82 % |
|
5yr Average Return on Assets
|
-10.42 % | 5.16 % | 18.52 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
57.92 % | 19.83 % | 63.34 % |
|
Share Pledged by Promoters
|
0.0 | 21.79 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
45.59 % | -2.22 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.04 % | 0.0 | 0.0 |
|
Oxygenta Pharma
|
Gennex Lab
|
Sat Kartar Shopping
|
|---|